GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parenteral Drugs (India) Ltd (BOM:524689) » Definitions » Accounts Receivable

Parenteral Drugs (India) (BOM:524689) Accounts Receivable : ₹0.00 Mil (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Parenteral Drugs (India) Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Parenteral Drugs (India)'s accounts receivables for the quarter that ended in Mar. 2022 was ₹0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Parenteral Drugs (India)'s Days Sales Outstanding for the quarter that ended in Mar. 2022 was 0.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Parenteral Drugs (India)'s Net-Net Working Capital per share for the quarter that ended in Mar. 2022 was ₹-438.60.


Parenteral Drugs (India) Accounts Receivable Historical Data

The historical data trend for Parenteral Drugs (India)'s Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parenteral Drugs (India) Accounts Receivable Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.65 - - - -

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Parenteral Drugs (India) Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Parenteral Drugs (India) Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Parenteral Drugs (India)'s Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/17.731*91
=0.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Parenteral Drugs (India)'s accounts receivable are only considered to be worth 75% of book value:

Parenteral Drugs (India)'s Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.001+0.75 * 0+0.5 * 10.274-13081.419
-0-1.225)/29.8163
=-438.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Parenteral Drugs (India) Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Parenteral Drugs (India) (BOM:524689) Business Description

Traded in Other Exchanges
N/A
Address
Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.

Parenteral Drugs (India) (BOM:524689) Headlines

No Headlines